摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Ethyl 3-(6-methylpyridin-3-yl)prop-2-enoate | 72716-74-6

中文名称
——
中文别名
——
英文名称
Ethyl 3-(6-methylpyridin-3-yl)prop-2-enoate
英文别名
——
Ethyl 3-(6-methylpyridin-3-yl)prop-2-enoate化学式
CAS
72716-74-6
化学式
C11H13NO2
mdl
——
分子量
191.23
InChiKey
UPQKGGCHMZDTBL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    14
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.27
  • 拓扑面积:
    39.2
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

点击查看最新优质反应信息

文献信息

  • Pyrimidine compounds
    申请人:Smith Kline & French Laboratories Limited
    公开号:US04649141A1
    公开(公告)日:1987-03-10
    The compounds are substituted pyrimidine compounds which are histamine H.sub.2 -antagonists. A specific compound of the present invention is 2-[2-(5-dimethylaminomethyl)-2-furylmethylthio)ethylamino]-5-(3-pyridylmet hyl)-4-pyrimidone.
    这些化合物是替代嘧啶化合物,是组胺H.sub.2-拮抗剂。本发明的一种特定化合物是2- [2- (5-二甲氨基甲基)-2-呋喃甲硫基)乙基氨基] -5-(3-吡啶甲基)-4-嘧啶酮。
  • Therapeutic phenoxyalkylheterocycles
    申请人:Sanofi, S.A.
    公开号:US05618821A1
    公开(公告)日:1997-04-08
    Compounds of the formula ##STR1## wherein Q is chosen from the group consisting of pyridyl, pyrazyl, pyrimidyl, quinolyl, indolyl and 7-azaindolyl or any of these substituted with one or two substituents; Y is an alkylene bridge of 3-9 carbon atoms; R.sub.1 and R.sub.2 are each independently chosen from hydrogen, halo, alkyl, alkenyl, amino, alkylthio, hydroxy, hydroxyalkyl, alkoxyalkyl, alkylthioalkyl, alkylsulfinylalkyl, alkylsulfonylalkyl, alkoxy, nitro, carboxy, alkoxycarbonyl, dialkylaminoalkyl, alkylaminoalkyl, aminoalkyl, difluoromethyl, trifluoromethyl or cyano; R.sub.3 is alkoxycarbonyl, alkyltetrazolyl, substituted or unsubstituted phenyl or heterocyclyl, the N-oxide thereof, or a pharmaceutically acceptable acid addition salt thereof is an effective antipicornaviral agent.
    公式为##STR1##的化合物,其中Q从吡啶基,吡唑基,嘧啶基,喹啉基,吲哚基和7-嗪啉基中选择,或者这些基团中的任何一个都被一个或两个取代基取代;Y是3-9个碳原子的烷基桥;R.sub.1和R.sub.2分别独立选择氢,卤素,烷基,烯基,氨基,烷硫基,羟基,羟基烷基,烷氧基烷基,烷硫基烷基,烷基亚磺酰基烷基,烷基磺酰基烷基,烷氧基,硝基,羧基,烷氧羰基,二烷基氨基烷基,烷基氨基烷基,氨基烷基,二氟甲基,三氟甲基或氰基;R.sub.3是烷氧羰基,烷基四唑基,取代或未取代的苯基或杂环基,其N-氧化物,或其药学上可接受的酸加合盐是有效的抗小肠病毒药物。
  • Intermediates in the process for making histamine antagonists
    申请人:Smith Kline & French Laboratories Limited
    公开号:US04227000A1
    公开(公告)日:1980-10-07
    A process for making substituted 2-aminopyrimidones which are histamine H.sub.2 - antagonists which comprises reacting a 2-nitroaminopyrimidone with a heteroarylalkylamine, heteroarylalkylthioalkylamine, or heteroarylalkoxyalkylamine. One particular compound which can be made by this process is 2-[2-(5-methyl-4-imidazolylmethylthio)ethylamino]-5-[5-(1,3-benzodioxolyl) methyl]-4-pyrimidone. Also claimed are 2-nitroaminopyrimidone intermediates for use in this process. One specific intermediate is 2-nitroamino-5-[5-(1,3-benzodioxolyl)methyl]-4-pyrimidone.
    一种制备取代的2-氨基嘧啶酮的方法,该嘧啶酮是组胺H.sub.2-拮抗剂,其包括将2-硝基氨基嘧啶酮与杂环烷基胺,杂环烷基硫代烷基胺或杂环烷基氧代烷基胺反应。可以通过此方法制备的一种特定化合物是2-[2-(5-甲基-4-咪唑基甲硫基)乙基氨基]-5-[5-(1,3-苯并二氧杂环基)甲基]-4-嘧啶酮。还声明了用于此过程的2-硝基氨基嘧啶酮中间体。其中一种特定的中间体是2-硝基氨基-5-[5-(1,3-苯并二氧杂环基)甲基]-4-嘧啶酮。
  • Phenyl alkylaminopyrimidones
    申请人:Smith Kline & French Laboratories Limited
    公开号:US04496567A1
    公开(公告)日:1985-01-29
    The compounds are phenyl alkylaminopyrimidones which are histamine H.sub.2 -antagonists. A specific compound of the present invention is 2-[2-[3-(dimethylaminomethyl)benzylthio]ethylamino]-5-(6-methyl-3-pyridylm ethyl)-4-pyrimidone.
    这些化合物是苯基烷基氨基嘧啶酮,是组胺H.sub.2-拮抗剂。本发明的一个具体化合物是2-[2-[3-(二甲氨基甲基)苄基硫基]乙基氨基]-5-(6-甲基-3-吡啶基甲基)-4-嘧啶酮。
  • Guanidinothiazolyl derivatives
    申请人:Smith Kline & French Laboratories Limited
    公开号:US04521418A1
    公开(公告)日:1985-06-04
    The compounds are guanidinothiazolyl derivatives which are histamine H.sub.2 -antagonists. A specific compound of the present invention is 2-[2-(2-guanidino-4-thiazolylmethylthio)ethylamino]-5-(6-methyl-3-pyridylm ethyl)-4-pyrimidone.
    这些化合物是鸟氨酸H.sub.2 -拮抗剂的胍基噻唑衍生物。本发明的一种特定化合物是2-[2-(2-胍基-4-噻唑基甲硫基)乙基氨基]-5-(6-甲基-3-吡啶基甲基)-4-嘧啶酮。
查看更多